Literature DB >> 20691967

Noninvasive diagnosis of pulmonary hypertension using heart sound analysis.

Aaron Dennis1, Andrew D Michaels, Patti Arand, Dan Ventura.   

Abstract

Right-heart catheterization is the most accurate method for measuring pulmonary artery pressure (PAP). It is an expensive, invasive procedure, exposes patients to the risk of infection, and is not suited for long-term monitoring situations. Medical researchers have shown that PAP influences the characteristics of heart sounds. This suggests that heart sound analysis is a potential method for the noninvasive diagnosis of pulmonary hypertension. We describe the development of a prototype system, called PHD (pulmonary hypertension diagnoser), that implements this method. PHD uses patient data with machine learning algorithms to build models of how pulmonary hypertension affects heart sounds. Data from 20 patients were used to build the models and data from another 31 patients were used as a validation set. PHD diagnosed pulmonary hypertension in the validation set with 77% accuracy and 0.78 area under the receiver-operating-characteristic curve.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691967     DOI: 10.1016/j.compbiomed.2010.07.003

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  9 in total

1.  The unique heart sound signature of children with pulmonary artery hypertension.

Authors:  Mohamed Elgendi; Prashant Bobhate; Shreepal Jain; Long Guo; Shine Kumar; Jennifer Rutledge; Yashu Coe; Roger Zemp; Dale Schuurmans; Ian Adatia
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  Prediction of pulmonary pressure after Glenn shunts by computed tomography-based machine learning models.

Authors:  Lei Huang; Jiahua Li; Meiping Huang; Jian Zhuang; Haiyun Yuan; Qianjun Jia; Dewen Zeng; Lifeng Que; Yue Xi; Jijin Lin; Yuhao Dong
Journal:  Eur Radiol       Date:  2019-11-08       Impact factor: 5.315

3.  Diagnosis of pulmonary hypertension from magnetic resonance imaging-based computational models and decision tree analysis.

Authors:  Angela Lungu; Andrew J Swift; David Capener; David Kiely; Rod Hose; Jim M Wild
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

4.  Utility of the physical examination in detecting pulmonary hypertension. A mixed methods study.

Authors:  Rebecca Colman; Heather Whittingham; George Tomlinson; John Granton
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Acoustic diagnosis of pulmonary hypertension: automated speech- recognition-inspired classification algorithm outperforms physicians.

Authors:  Tarek Kaddoura; Karunakar Vadlamudi; Shine Kumar; Prashant Bobhate; Long Guo; Shreepal Jain; Mohamed Elgendi; James Y Coe; Daniel Kim; Dylan Taylor; Wayne Tymchak; Dale Schuurmans; Roger J Zemp; Ian Adatia
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

6.  The Voice of the Heart: Vowel-Like Sound in Pulmonary Artery Hypertension.

Authors:  Mohamed Elgendi; Prashant Bobhate; Shreepal Jain; Long Guo; Jennifer Rutledge; Yashu Coe; Roger Zemp; Dale Schuurmans; Ian Adatia
Journal:  Diseases       Date:  2018-04-13

7.  Identification of Pulmonary Hypertension Using Entropy Measure Analysis of Heart Sound Signal.

Authors:  Hong Tang; Yuanlin Jiang; Ting Li; Xinpei Wang
Journal:  Entropy (Basel)       Date:  2018-05-21       Impact factor: 2.524

8.  TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients.

Authors:  Wenjun He; Chunli Liu; Jing Liao; Fei Liu; Hui Lei; Danmei Wei; Honglian Ruan; Bibhav Kunwar; Wenju Lu; Jian Wang; Tao Wang
Journal:  Front Med (Lausanne)       Date:  2022-02-25

9.  Cardiac acoustic biomarkers as surrogate markers to diagnose the phenotypes of pulmonary hypertension: an exploratory study.

Authors:  Nobuhide Yamakawa; Norihiko Kotooka; Tomoyuki Kato; Tatsuhiko Kuroda; Koichi Node
Journal:  Heart Vessels       Date:  2021-10-01       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.